Lyophilized human plasmas with a residual Factor VIII, IX, XI or XII of ≦1%. Fibrinogen is present in a quantity of at least 1 g/L and the remaining extrinsic pathway factors are present in an activity greater than 40% of the

申請商
台灣希森美康股份有限公司 
適應症
使用凝固測量法測定人類血漿中的凝固因子9之活性的體外診斷試劑。
含量
0